The QualityStocks Daily Tuesday, December 21st, 2021

Today's Top 3 Investment Newsletters

MarketClub Analysis(BFRIW) $6.4500 +126.32%

PennyStockProphet(RELI) $5.4500 +78.69%

QualityStocks(RKFL) $0.3199 +27.76%

The QualityStocks Daily Stock List

Jaguar Health (JAGX)

QualityStocks, MarketBeat, StockMarketWatch, BUYINS.NET, StreetInsider, InvestorPlace, The Online Investor, StockRockandRoll, Schaeffer's, PennyStockLocks, Penny Stock 101, DreamTeamNetwork, MarketClub Analysis, Promotion Stock Secrets, Wealth Insider Alert, Stock Beast, Trades Of The Day and PoliticsAndMyPortfolio reported earlier on Jaguar Health (JAGX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jaguar Health Inc. (NASDAQ: JAGX) (FRA: 1JA2) is a commercial-stage pharmaceuticals firm that is focused on developing and commercializing gastrointestinal products for animals and human prescription use and non-prescription gastrointestinal animal products.

Jaguar Health has its headquarters in San Francisco, California and serves the human and animal health markets across the globe. The firm was established on June 6, 2013 by Lisa A. Conte.

Through its Napo Pharmaceuticals Inc. subsidiary, Jaguar Health Inc. develops and commercializes proprietary human gastrointestinal products. This is in addition to operating through 2 segments: Animal health segment and Human health segment. The former segment commercializes non-prescription and prescription products for production and companion animals while the latter segment develops human products and advertises one of the firm’s products called Mytesi which is used to provide symptomatic relief of non-infectious diarrhea in adults on ARV therapy for HIV/AIDS.

Jaguar Health Inc.’s human products include a crofelemer formulation which is currently undergoing a phase 2 clinical trial for the treatment of irritable bowel, functional/idiopathic diarrhea, congenital diarrheal disorder and short bowel syndrome; crofelemer, which is in its phase 3 clinical trials for supportive care for inflammatory bowel disease and treatment of diarrhea associated with cancer therapy. The firm’s animal products include Neonorm Foal and Neonorm Calf, as well as a non-prescription product for gut health in equine athletes known as Equilevia and an animal prescription drug candidate indicated for the treatment of diarrhea in dogs induced by chemotherapy, called Canalevia.

Jaguar Health Inc. recently incorporated its Napo EU subsidiary in anticipation of its merger with Italian Dragon SPAC, which will broaden the firm’s consumer base overseas and boost growth. The subsidiary will help address the increasing burden of inflammatory diarrhea that has been linked to long-hauler syndrome in the post-coronavirus patient population over in Europe.

Jaguar Health (JAGX), closed Tuesday’s trading session at $1.38, up 20%, on 88,588,666 volume. The average volume for the last 3 months is 88.248M and the stock's 52-week low/high is $0.9897/$13.41.

RocketFuel Blockchain, Inc. (RKFL)

QualityStocks and SeeThruEquity Research reported earlier on RocketFuel Blockchain, Inc. (RKFL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

RocketFuel Blockchain, Inc. is a developer of blockchain-based check-out technologies for eCommerce and brick and mortar retailers. The OTCQB-Listed Company is developing blockchain-based technologies to bring highly efficient check-out and privacy protection solutions to its customers. The design of the blockchain technologies developed by RocketFuel are to focus on enhanced customer privacy protection, eliminating the risk of data breach while increasing the speed, the security, and also the ease of use. Established in 2018, RocketFuel Blockchain has its corporate office in Las Vegas, Nevada.

RocketFuel Blockchain’s belief is that users of its technologies will be able to enjoy seamless check-out and forget about the awkward cart paradigm of the past. In addition, the Company’s belief is that merchants will be able to implement new impulse buying schemes and create new sales channels, which may be unavailable in current day eCommerce websites.

RocketFuel’s emphasis is on payment checkout reinvented. The focus is next-generation payment experiences that makes passwords and filling out forms a thing of the past. The RocketFuel blockchain based one-click “BUY-NOW” check-out solution is an innovative technology. It promotes significant high conversion efficiencies. Furthermore, it further promotes highly impulsive buying in e-commerce scenarios. It ensures very high payment security and privacy infrastructure.

For Consumers, no money is stored. The App is not an eWallet; funds are not administratively held. For Merchants, it features first-rate conversion efficiencies. Less checkout problems creates considerably higher conversion rates. It promotes impulse buying - frictionless impulse buying to effect immediate online purchases. It eliminates costly intermediaries and creates immediate payments.

RocketFuel Blockchain previously announced that it appointed Mr. Peter M. Jensen as its Chief Executive Officer, effective September 15, 2020. Mr. Jensen is a well-known Silicon Valley executive. He has more than three decades experience in technology, having served in senior positions with Oracle and Symantec.

RocketFuel Blockchain announced that on October 2, 2020 it appointed Mr. Rohan Hall as its Chief Technology Officer (CTO). Mr. Hall has greater than three decades experience in technology as a founder of a number of successful companies. He has built and implemented technology solutions for numerous Fortune 500 companies and start-ups. These include HP, PeopleSoft/Oracle, Corning, Honda, as well as American Red Cross. In addition, he is a well-known author and frequent speaker on topics including blockchain, cryptocurrencies, FinTech and related technologies.

RocketFuel Blockchain, Inc. (RKFL), closed Tuesday’s trading session at $0.3199, up 27.7556%, on 158,016 volume. The average volume for the last 3 months is 158,016 and the stock's 52-week low/high is $0.205/$5.75.

Creative Medical Technology Holdings (CELZ)

QualityStocks and Schaeffer's reported earlier on Creative Medical Technology Holdings (CELZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Creative Medical Technology Holdings, Inc. (OTC: CELZ) is a clinical-stage biotechnology firm that is engaged in the treatment of various neurological, orthopedic, urological and immunological ailments such as stroke and erectile dysfunction, using adult stem cell treatments.

The firm is based in Phoenix, Arizona and was incorporated in 1998, on December 3. The enterprise, together with Creative Medical Health Inc. its affiliate company, is focused on regenerative medical solutions for unmet neurological and urological needs. Their team is made up of international researchers focused on regenerative medicine, whose approach to treatments makes sure that all treatments are proven to be both effective and safe.

Through partnerships with leading academic institutions and researchers, the firm has developed treatments for erectile dysfunction, established an extensive intellectual property portfolio, developed proprietary protocols and obtained Amniostem; a groundbreaking stem cell. The company is currently breaking new ground for the treatment of stroke using its amniotic-fluid based stem cell and recently launched a patient trial for erectile dysfunction at UCLA.

The firm’s product portfolio includes a treatment indicated for female infertility called OvaStem; a candidate developed for stroke patients, dubbed ImmCelz; Amniostem for the treatment of glioma, toxicity and strokes; a treatment developed for chronic lower back pain christened StemSpine; a candidate indicated for the treatment of genital dryness and loss of genital sensitivity and a treatment developed for erectile dysfunction called CaverStem.

Creative Medical Technology Holdings Inc. recently announced that the FDA issued an Investigational New Drug number to the firm’s ImmCelz candidate, which was developed to treat stroke patients. This is a major milestone for the firm and may lead to the candidate being approved for commercialization and use in the near future, which will be beneficial not only to the patients whose needs will be met but also to the company.

Creative Medical Technology Holdings (CELZ), closed Tuesday’s trading session at $2.14, up 17.5824%, on 4,025,659 volume. The average volume for the last 3 months is 4.026M and the stock's 52-week low/high is $0.0024/$9.00.

Aehr Test Systems (AEHR)

Wall Street Resources, TradersPro, StreetInsider, SmarTrend Newsletters, QualityStocks, PennyToBuck, TraderPower, MarketClub Analysis, PennyOmega, StockHotTips, Marketbeat.com, DrStockPick, CRWEWallStreet, CRWEPicks, CRWEFinance, BestOtc, MarketBeat, Promotion Stock Secrets, Street Insider, Barchart, Wealth Insider Alert, Schaeffer's, Money Morning, StockMarketWatch, StockOodles, TopPennyStockMovers, The Street, Wall Street Mover, Trading Concepts, Investing Futures, RedChip, InvestorPlace, Zacks, Stock Fortune Teller, PoliticsAndMyPortfolio and Investopedia reported earlier on Aehr Test Systems (AEHR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aehr Test Systems (NASDAQ: AEHR) (FRA: AYB) is a firm that is engaged in engineering, designing, manufacturing and selling burn-in and test equipment used in the semiconductor industry in Europe, Asia and the U.S.

The firm has its headquarters in Fremont, California and was incorporated in 1977. It operates in the technology sector, under the tech hardware and semiconductors industry, in the semi-conductors’ sub-industry.

The company sells and markets its products to test and burn-in service companies, electronics manufacturers, semiconductor contract assemblers and semiconductor manufacturers via a network of sales representatives and distributors. It provides test fixtures, test during burn-in systems, full wafer contact test systems and related accessories.

Its products include FOX systems, which include test and burn-in systems that have been designed to achieve contact with pads of a wafer at the same time; a DiePak carrier, which allows manufacturers of integrated circuits to carry out tests and burn-in of small or singulated bare multi-integrated circuit modules; the DiePak Loader, which carries out automatic loading of the DiePak carrier’s modules and the WaferPak Aligner, designed to carry out automatic alignment of the wafer to the WaferPak contractor. The enterprise also offers customer support and service programs, which include documentation services, customer training, applications engineering support, system repair and system installation.

The firm recently received a follow-on order worth more than $2 million for its FOX-XP Wafer Level Test and Burn-in system from a major Fortune 500 supplier of semi-conductor devices. This not only highlights the quality of the firm’s products but also boosts their popularity in the market, which will encourage more investments into the firm.

Aehr Test Systems (AEHR), closed Tuesday’s trading session at $18.12, up 17.8153%, on 3,426,349 volume. The average volume for the last 3 months is 3.369M and the stock's 52-week low/high is $1.94/$27.09.

Eco Depot, Inc. (ECDP)

StockRockandRoll, StockLockandLoad, StockBomb.com, PennyStocks24, PennyStockLocks.com, Michael Stone, Research Driven Investor, Growing Stocks Reports, Xtreme Stock Picks, SmallCapInvestorDaily, Super Hero Stocks, RagingStock Bull, QualityStocks, Pumps and Dumps, JackpotStock Picks, PennyStock Tweets, PennyStock PayCheck, PennyStock MarketBulls, PennyDoctor, Wallstreet Profiler, Blaque Capital Stocks, The Observer, InvestorTrendz, Penny Stocks VIP, Penny Stock Mobsters, Penny Pick Insider, Email Stock Picks, Stockgoodies, Daily Stock Motion, SuperStockTips, Darth Trader, Wall Street Beauties, Penny Stocks On Steroids, Beacon Equity Research, Penny Stocks Finder, InvestorSoup, MassiveStockProfits, POSstocks, PremiereStockAlerts, MajorPennyStocks, The Stock Psycho, StockProfessors, StockMarketIntel, Stock Preacher, Penny Stock Craze, smartOTC, WINNINGOTC, SizzlingStockPicks, PennyStockScholar, OTCtipReporter, Penny Picks, ResearchOTC, Equity Observer, Research Driven Alerts, Jet-Life Penny Stocks, OtcShortReport, Damn Good Penny Picks, BestDamnPennyStocks, DSR News, eliteotc.com, LuckyStockPicks, Liquid Tycoon, Liquid Pennies, Joe Penny Stocks, EpicVIP Group, FOX Penny Stocks, HotStockProfits, Greenbackers, HEROSTOCKS, Epic Stock Picks, SmallCap Fortunes, Winning Penny Stock Picks, WePickPennyStocks, WallstreetsHotteststocks, Wallstreetbuzz, VIP STOCK ALERTS, Value Penny Stocks, USA Market News, Top Stock Picks, TheNextBigTrade and SuperHotPennyStocks reported earlier on Eco Depot, Inc. (ECDP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Eco Depot, Inc. acquires, manages, as well as develops eco-friendly real estate assets and consumer brand products. The Company’s focus is to provide investments, funding, and support for acquisitions, start-ups, entrepreneurs, and green companies committed to protecting the environment. A Nevada company, and founded in 2004, Eco Depot lists on the OTC Markets. The Company is headquartered in Las Vegas, Nevada.

Currently, Eco Depot is focused on commercializing Bronya Climate Shield. This is a versatile thermal insulation paint capable of increasing energy efficiency and decreasing carbon emissions.

Bronya Climate Shield™ is a multi-purpose liquid insulation. It can be applied on any surface, indoors and outdoors, at temperatures of -60 °C up to +200 °C. Bronya Climate Shield is a cost-effective Do-It-Yourself (DIY) product with thermal conductivity of 0,001 W/m Celsius. It is proven to lessen energy costs by up to 40 percent and labor costs by 70 percent. In addition, the product provides insulation lasting from 10 to 30 years, depending on the application.

Eco Depot previously announced it completed labs to meet the ISO Fire Retardant Standards for Nordic Structures prefabricated I-Joist building products manufacturing. Lab results from studies conducted by FPInnovations, sponsored by Nordic Structures, as a potential economic advantage to fire proofing OSB manufactured I-Joists, have marked Bronya Climate Shield Thermal Liquid Insulation as "Promising" and functionally meeting ISO minimum Fire Retardant Standards. The lab results will be made available in a supplementary filing. They are also available by request at Eco Depot corporate.

Eco Depot, Inc. (ECDP), closed Tuesday’s trading session at $0.3805, up 23.0993%, on 173,946 volume. The average volume for the last 3 months is 173,946 and the stock's 52-week low/high is $0.30/$5.58.

BioVie Inc. (BIVI)

QualityStocks, RedChip, Wealth Insider Alert and Red Chip reported earlier on BioVie Inc. (BIVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioVie Inc. (NASDAQ: BIVI) is a clinical stage biotechnology firm that is engaged in discovering, developing and commercializing drug therapies, with a focus on liver disease.

The firm has its headquarters in Santa Monica, California and was incorporated in 2013, on April 10th. Prior to its name change in July 2016, the firm was known as NanoAntibiotics Inc. The firm serves consumers around the world.

The company is focused on developing transformative therapies that will meet significantly unmet medical needs for patients suffering from chronic debilitating conditions. Its initial disease targets are conditions which impact individuals across the globe.

The enterprise’s product portfolio comprises of an ERK inhibitor dubbed NE3107, which is in its pre-clinical stage and has been developed to treat prostate cancer and multiple myeloma. This formulation, which also selectively decreases insulin resistance and neuro-inflammation, is also undergoing a phase 1 clinical trial and a phase 3 clinical trial evaluating its effectiveness in treating Parkinson’s disease and Alzheimer’s disease respectively. It also develops BIV201, which has concluded its phase 2 clinical trial testing its efficacy in treating ascites due to chronic liver cirrhosis. This formulation is also a treatment option for patients with complications of advanced liver cirrhosis brought about by alcoholism, non-alcoholic steatohepatitis and hepatitis. BIV201 has an Orphan Drug designation for hepatorenal syndrome treatment.

The company recently began patient trials for its BIV201 candidate for Alzheimer’s, which shows promise as a potential treatment. The success of the company’s BIV201 formulation in treating this degenerative disease would not only meet the unmet needs of patients with this indication but also bring in more investors into the company, which would boost the company’s growth.

BioVie Inc. (BIVI), closed Tuesday’s trading session at $5.6, up 18.1435%, on 114,776 volume. The average volume for the last 3 months is 114,776 and the stock's 52-week low/high is $4.58/$46.0977.

Pioneer Power Solutions, Inc. (PPSI)

MarketClub Analysis, TradersPro, QualityStocks, Wall Street Resources, StockMarketWatch, TraderPower, Marketbeat.com, Trading Concepts, Trades Of The Day, The Street, Street Insider, MarketBeat and Investing Futures reported earlier on Pioneer Power Solutions, Inc. (PPSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pioneer Power Solutions, Inc. engages in the manufacture, sale, and service of electrical transmission, distribution, and on-site power generation equipment. This is for applications in the utility, industrial, commercial, as well as backup power markets. Its main products include switchgear and engine-generator controls, complemented by a national field-service network to maintain and repair power generation assets.

Established in 2008, Pioneer Power Solutions has its head office in Fort Lee, New Jersey. The Company lists on the NasdaqCM (Nasdaq Capital Market). Pioneer Power Solutions, Inc. is a subsidiary of Provident Pioneer Partners, L.P.

Pioneer Power Solutions’ business operations cover about 200 employees at seven manufacturing, engineering, sales, and marketing locations in the United States. The Company is an industry leader in the design and manufacture of electrical equipment for customers in the North American industrial, commercial, OEM (Original Equipment Manufacturer) and critical power markets. Its product portfolio includes a broad spectrum of specialty magnetic products used in the control and conditioning of electrical current for critical processes.

Pioneer’s T&D Solutions business provides equipment solutions that help customers effectively and efficiently manage their electrical power distribution systems to desired specifications. Pioneer’s Critical Power business provides engine-generator sets and controls. The Critical Power business is supported by the Company’s nationwide field service organization for emergency standby power systems and distributed generation applications.

Pioneer Power Solutions previously announced that it secured a $3.5 million order from a large global container shipping company. Pioneer will supply a highly customized energy solution, including two integrated power centers with redundant 15kv medium voltage switchgear, an integrated power control building, and an integrated double-ended 750kva unit substation. The equipment will help deliver reliable and redundant power to the shipping company's main terminal in Hawaii.

Pioneer Power Solutions also announced that it was awarded an initial service contract for preventative maintenance and repairs by one of the largest home improvement retailers in the United States. Pioneer will provide scheduled generator preventative maintenance and emergency repair services for the retailer’s engine generator equipment assets at 24 of its greater than 300 store locations.

Pioneer Power Solutions, Inc. (PPSI), closed Tuesday’s trading session at $8.32, up 18.0142%, on 15,197,480 volume. The average volume for the last 3 months is 15.161M and the stock's 52-week low/high is $3.0904/$14.4299.

VirnetX Holding Corporation (VHC)

All about trends, MarketClub Analysis, StockMarketWatch, SmallCap Network, MarketBeat, INO.com Market Report, Jason Bond, StreetInsider, Hit and Run Candle Sticks, The Street, TradingMarkets, SmarTrend Newsletters, QualityStocks, Schaeffer's, Street Insider, Wall Street Corner, BUYINS.NET, Equity Observer, Greenbackers, SmallCapVoice, PowerRatings Stocks, Money Morning, AlphaPennyStock, AwesomeStocks, Barchart, Value Penny Stocks, TraderPower, ProfitableTrading, Rick Saddler, StockOodles, SmallCapNetwork, Stock Twiter, Stock Beast, SuperStockHunter, Stocks That Move, Taipan Daily, Cabot Wealth, CustomerService, Energy and Capital, Equities.com, FNNO Newsletters, GreatStockPix, Stock Specialists, Total Wealth, Hot Stock Profits, Timothy Sykes, Investing Futures, Investment House, Uncommon Wisdom, Market Wrap Daily, Short Term Wealth, The Stock Detective, StreetAuthority Daily, PoliticsAndMyPortfolio, SmallCapInvestor.com, TopStockAnalysts, Wall Street Resources, Top Stock Picks and Stock Market Authority reported earlier on VirnetX Holding Corporation (VHC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

VirnetX Holding Corporation (NYSE: VHC) (FRA: VN2) is an internet security firm that is focused on the development of software and technology solutions for securing real-time communication over the internet.

The firm has its headquarters in Zephyr Cove, Nevada and was incorporated in 2005, on August 5th. It operates as part of the software and technology industry, under the technology sector. The firm serves consumers around the globe, with a focus on the United States. It has three companies in its corporate family.

The company develops software and technology solutions which have been designed to secure over-the-internet communications, as well as allow individuals and organizations to establish communities of secure, registered users and transmit information between different operating systems, networks and devices.

The enterprise provides a portfolio of licenses and services, which include Gabriel Connection Technology software development kit, which includes testing and quality assurance tools, documentation required for technology implementation, sample code and object libraries; VirnetX technology licensing, secure domain name master connection and registry, relay server software, connection server software, registrar server software, and technical support services. It also offers the Gabriel Collaboration Suite that allows secure and seamless cross-platform communications between user devices. The enterprise serves system integrators, domain infrastructure and communication services providers, original equipment manufacturers of net books, laptops, e-Readers, tablets, smartphones, servers, chips and other devices in the fixed-mobile convergence, mobility, IP-telephone and unified communications markets.

The company’s technology is poised for explosive growth in the Asian markets, Japan in particular. It is focused on extending its consumer reach into new regions and establishing relationships with major players in Japan, which will be good for its growth as well as investments.

VirnetX Holding Corporation (VHC), closed Tuesday’s trading session at $2.89, up 0.696864%, on 536,575 volume. The average volume for the last 3 months is 534,544 and the stock's 52-week low/high is $2.58/$8.24.

Spruce Biosciences (SPRB)

StreetInsider and MarketBeat reported earlier on Spruce Biosciences (SPRB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spruce Biosciences Inc. (NASDAQ: SPRB) is a biopharmaceutical firm that is focused on the development and commercialization of new therapies for rare endocrine disorders.

The firm has its headquarters in Daly City, California and was incorporated in 2014, on November 13th. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers in the United States.

The company’s mission is to develop meaningful therapies for patients with rare ailments which affect the hypothalamic-pituitary-adrenal pathway. It is party to a license agreement with Eli Lilly and Company, which entails the research, development and commercialization of compounds for different pharmaceutical uses. The company is committed to transforming the quality of life for patients who’ve been underserved by scientific innovation.

The enterprise’s portfolio comprises of a non-steroidal therapy dubbed tildacerfont, which has been developed to decrease steroid burden and improve disease control for patients who suffer from CAH (congenital adrenal hyperplasia). The formulation is in phase 2 clinical trials being evaluated for its effectiveness in treating children with classic congenital adrenal hyperplasia, as well as for females with polycystic ovary syndrome. It also develops CAHmelia-203, which is in phase 2b trials for adults with classic CAH with poor and good disease control.

The company recently released its third quarter financial results for 2021, with its CEO noting that it was focused on advancing its tildaverfont formulation for congenital adrenal hyperplasia and polycystic ovarian syndrome. The success and approval of this formulation will address the unmet needs of patients with these indications, as well as bring in more investments into the company.

Spruce Biosciences (SPRB), closed Tuesday’s trading session at $4.17, off by 2.3419%, on 9,086,834 volume. The average volume for the last 3 months is 9.087M and the stock's 52-week low/high is $2.25/$28.49.

Gold Royalty Corp (GROY)

QualityStocks, MarketClub Analysis and InvestorPlace reported earlier on Gold Royalty Corp (GROY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gold Royalty Corp (NYSE American: GROY) (FRA: 6LS0) is a royalty and streaming firm focused on precious metals which is engaged in providing financing solutions to the mining and metals industry.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2020, on June 23rd. It serves consumers around the globe.

The company is focused on the acquisition of streams, royalties and similar interests at different stages of the mine lifecycle to build a portfolio which offers short-term, medium and long-term attractive returns for its investors. It is committed to furthering responsible and sustainable mineral development as a means to create long-term value for its stakeholders.

The enterprise holds NSR (net smelter royalties) associated with advance-stage resource and development projects. Its diversified portfolio comprises of more than 180 royalties located in various mining jurisdictions in the Americas. These include net smelter return royalties ranging from 0.5% to 2% on 18 gold properties which cover 12 projects in the Americas.The enterprise’s projects include Whistler, Almaden, Batistao, Troy, War Eagle, Shamrock, Scossa, Redlich Gold, Monte Cristo, La Mina, Hog Ranch and Fenelon, among others. The royalties offer investors lower risk exposure to gold with free exploration upside on the underlying projects.

The company recently successfully completed its business combination with Abitibi Royalties Inc. and Golden Valley Mines and Royalties Ltd. This move expands the company’s portfolio and increases its presence in Nevada and Quebec, which are among the most favored mining regions globally. This will have a positive influence on investments into the company as well as its growth.

Gold Royalty Corp (GROY), closed Tuesday’s trading session at $4.85, up 0.831601%, on 392,012 volume. The average volume for the last 3 months is 391,869 and the stock's 52-week low/high is $3.39/$7.08.

Genfit S.A. (GNFT)

MarketBeat, Trades Of The Day, Daily Trade Alert, StreetInsider, StockMarketWatch, MarketClub Analysis and FreeRealTime reported earlier on Genfit S.A. (GNFT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Genfit S.A. (NASDAQ: GNFT) (FRA: XUP) is a biopharmaceutical firm that is engaged in the discovery and development of diagnostic solutions and drug candidates for inflammatory and metabolic ailments, with a particular focus on the liver and gastroenterology.

The firm has its headquarters in Loos, France and was incorporated in September 1999, by Bart Staels, Florence Séjourné and Jean-François Mouney. It serves consumers around the globe.

The company’s research and development activity is dependent on its expertise in gene expression modulation through nuclear receptors. It uses strategic alliances, licensing agreements and acquisitions to finance the development of its products. For instance, the company is party to a licensing agreement with Labcorp, which involves commercializing a blood-based molecular diagnostic test known as NASHnext. It carries out clinical trials in various North American and European countries when advancing through stages of development.

The enterprise is focused on developing drug candidates in high unmet medical need areas, corresponding to a lack of suitable therapies. Its product pipeline comprises of Elafibranor, which is in phase III clinical trials and is indicated for the treatment of primary biliary cholangitis. It also develops NIS4 technology, which is used to diagnose fibrosis and NASH (nonalcoholic steatohepatitis).

The company recently entered into a long-term strategic partnership agreement with Ipsen, which gives the company the license to manufacture and commercialize Elafibranor. This move will, in addition to having a positive impact on the lives of patients with life-threatening illnesses, accelerate the company’s growth and generate value for its shareholders.

Genfit S.A. (GNFT), closed Tuesday’s trading session at $5.3, off by 6.1947%, on 631,071 volume. The average volume for the last 3 months is 631,071 and the stock's 52-week low/high is $3.01/$7.19.

X4 Pharmaceuticals (XFOR)

MarketBeat, InvestorPlace, StockMarketWatch and BUYINS.NET reported earlier on X4 Pharmaceuticals (XFOR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

X4 Pharmaceuticals Inc. (NASDAQ: XFOR) (OTC: XFORW) (FRA: 48Q) is a clinical-stage biopharmaceutical firm that is focused on research, developing and commercializing new therapeutics for rare disease treatment.

The firm has its headquarters in Boston, Massachusetts and was incorporated in 2014. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers in the United States and has three companies in its corporate family.

The company specializes in the development of new therapeutics that are designed to improve immune cell trafficking. Its oral small molecule drug candidates antagonize the chemokine receptor CXCR4 pathway, which plays a crucial role in immune surveillance. It is party to a license agreement with Abbisko Therapeutics Co. Ltd, which involves developing, manufacturing and commercializing mavorixafor in combination with checkpoint inhibitors in oncology indications.

The enterprise’s product pipeline is made up of an oral small molecule CXCR4 antagonist dubbed mavorixafor, which is in phase 3 clinical trials for the treatment of myelokathexis syndrome, infections, hypogammaglobulinemia and warts. The formulation is also in phase 2a trials testing its effectiveness in treating clear cell renal cell carcinoma; and in phase 1b clinical trials for the treatment of Waldenstrommacroglobulinemia and severe congenital neutropenia. In addition to this, the enterprise is also developing X4P-003 for the treatment of chronic rare diseases and X4P-002, for glioblastoma multiforme treatment.

The firm is currently focused on expanding its commercial expertise. It recently appointed a new Vice President who has extensive experience in strategic marketing and global product launch and commercialization. The move will allow the firm to successfully prepare for the anticipated launch of its mavorixafor formulation, which will have a positive effect on the firm’s growth.

X4 Pharmaceuticals (XFOR), closed Tuesday’s trading session at $2.34, off by 3.7037%, on 617,606 volume. The average volume for the last 3 months is 613,899 and the stock's 52-week low/high is $1.80/$10.7038.

The QualityStocks Company Corner

Growth Capital Acquisition Corp. (NASDAQ: GCAC)

The QualityStocks Daily Newsletter would like to spotlight Growth Capital Acquisition Corp. (NASDAQ: GCAC).

Growth Capital Acquisition Corp. (NASDAQ: GCAC) was featured today by InvestorWire as ‘One to Watch.’

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on February 2, 2021, with $172.5 million in Trust, and Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT® lidar solutions, on August 5, 2021, announced their entry into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed ‘Cepton Inc.’ and is expected to be listed on the Nasdaq stock exchange under new ticker symbol ‘CPTN’.

The proposed business combination, which has been unanimously approved by the boards of directors of Cepton and Growth Capital, is expected to be completed early in the first quarter of 2022, subject to, among other things, approval by Growth Capital’s stockholders, satisfaction of the conditions stated in the definitive agreement and other customary closing conditions.

Cepton Technologies Inc. is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s proposed merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Growth Capital Acquisition Corp. (NASDAQ: GCAC), closed Tuesday’s trading session at $9.97, up 0.4534%, on 133 volume. The average volume for the last 3 months is 133 and the stock's 52-week low/high is $9.55/$9.99.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX) is embarking on new programs as well as extending ongoing ones as it pursues regulatory approvals and entry into different market sectors. In January 2022, the company expects to report blood pressure findings from its third human hypertension study, HYPER-H21-3, building on the successes of the first two human studies that evidenced effective, sustained and safe blood pressure reduction with DehydraTECH-CBD. The company will also be expecting approvals for the protocols around its fourth hypertension study, HYPER-H21-4, which is just one of the many planned studies slated for 2022. “Others include HOR-A22-1, a pharmacokinetic study to evaluate DehydraTECH’s ability to improve the delivery characteristics of estrogen; DEM-A22-1, an efficacy modeling study to evaluate DehydraTECH-CBD with and without nicotine for the potential treatment of dementia; RHEUM-A22-1, an efficacy modeling study to investigate the ability of DehydraTECH-CBD to potentially affect the treatment of rheumatoid disease; and DIAB-A22-1, an efficacy modeling study to explore DehydraTECH-CBD’s ability to potentially impact treatment of diabetes,” explains a recent article. “In addition to fulfilling Lexaria’s goal to enter into new, different multibillion markets, the four animal studies will mark the company’s push to help patients living with these conditions, some of which are potentially fatal.” To view the full article, visit: https://cnw.fm/93Tti

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules.  DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Tuesday’s trading session at $4.4, up 5.7692%, on 107,588 volume. The average volume for the last 3 months is 104,722 and the stock's 52-week low/high is $3.9751/$12.50.

Recent News

Cybin Inc. (NEO: CYBN) (OTC: CYBN)

The QualityStocks Daily Newsletter would like to spotlight Cybin Inc. (NEO: CYBN) (NYSE American: CYBN).

Cybin (NYSE American: CYBN) (NEO: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in two premier events: the 11th annual LifeSci Partners Annual Corporate Access Event and the H.C. Wainwright Bioconnect Conference. Cybin CEO Doug Drysdale will participate in both upcoming virtual investor events. At the LifeSci Partners event, scheduled for Jan. 5–7, 2021, Drysdale will be involved in a panel discussion titled “Psychedelics: More Than Just a Trip.” The panel is slated for Wednesday, Jan. 5, at 10 a.m. ET. At the H.C. Wainwright Bioconnect Conference, Drysdale willparticipate in a fireside chat, which is scheduled for Jan. 10. at 7 a.m. ET. The Bioconnect conference will be held Jan. 10–13, 2022. To view the events, visit https://ibn.fm/OePOt and https://ibn.fm/oepko. To view the full press release, visit https://ibn.fm/C1C9U. The holidays, family gatherings and holiday celebrations are often filled with fun, good food and alcohol on occasion. Individuals with alcohol addiction may be vulnerable during this time, especially if they’re being invited to places with booze. Ideally, not having alcohol around would be best, but that isn’t always possible. Addiction psychiatrist Dr. Lauren Grawert gives a few tips on how to handle situations like this. Many companies, including Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), are working to bring to market superior formulations made from novel pharmaceutical active ingredients so that patients can enjoy better outcomes from their addiction treatment.

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), closed Tuesday’s trading session at $1.21, up 3.4188%, on 1,089,257 volume. The average volume for the last 3 months is 1.087M and the stock's 52-week low/high is $0.95/$3.38.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF) CEO, cofounder and chair Shone Anstey is the featured guest in a recent episode of the Gamechangers LIVE podcast series. Hosted by executive coach Sergio Tigera, Gamechangers LIVE shines a spotlight on individuals who are gamechangers in their fields and provides a platform for them to share their perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. During his interview, Anstey talked about his background and expertise in the cryptocurrency industry; he also discussed the sustained growth of Bitcoin’s Lightning Network and provided an overview of LQwD Fintech and its promising future. “The Lightning Network solves Bitcoin’s scalability issue,” said Anstey in the interview. “At seven transactions per second, Bitcoin is very slow and very secure. If you want to transfer $100 million worth of Bitcoin, the main network is absolutely acceptable . . . but if you want to use Bitcoin every day for coffee or purchases or remittances of smaller denominations, the Lightning Network allows you to send really small amounts more quickly. . . . It offers a real solution to the scaling problem. . . . We’re seeing really rapid growth of the Lightning Network over the last five years, with a 205% increase in growth of the network in terms of nodes, channels and capital this year alone.” To view the full interview, visit https://ibn.fm/pyR69. To view the full press release, visit https://ibn.fm/luI9s.

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Tuesday’s trading session at $0.3075, up 6.5489%, on 24,004 volume. The average volume for the last 3 months is 24,004 and the stock's 52-week low/high is $0.25/$4.00.

Recent News

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF)

The QualityStocks Daily Newsletter would like to spotlight StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF).

Space mining is the exploitation of minerals from bodies in outer space. This type of mining has been heralded as a new way to obtain minerals without the environmental risks associated with land mining. This is in addition to revolutionizing the commercial space economy by creating employment opportunities for private astronauts and robots. Many believe that space mining is the future because it can facilitate the exploration for and extraction of precious metals and rare earth minerals from near-Earth asteroids. However, little has been done to advance the idea. Recently, an egg-shaped, near-Earth asteroid with a 330-meter diameter passed near our planet, which started this discussion again. Researchers believe that this asteroid, dubbed 4660 Nereus, contains precious metals worth about $5 billion. The asteroid didn’t come as close to Earth as many thought, given that it was closest to our home planet at almost 4 million kilometers away. This distance is roughly 10 times the distance between the moon and Earth. Fortunately, when Nereus passes by our planet in 2060, it will still be far away at five times the distance between the moon and the Earth. It would be interesting to see how the effect of space mining would have on the operations of mining entities such as StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF).

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) is a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America. The company’s flagship properties are located in the Red Lake Mining District of Ontario, Canada, renowned for over 30 million ounces of historic gold production. Other key projects extend into the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. The company’s management team is led by dedicated professionals, aiming to maximize shareholder value while employing modern exploration techniques and principles to achieve its goals.

The mission of StraightUp Resources is to maximize shareholder wealth through mineral discoveries at projects with robust potential, maintain long-lasting partnerships, and continue to focus on the acquisition, development and exploration of mineral resource properties in North America. The company’s objective is to continue to locate and develop economic, precious and base metal properties of merit.

The company’s 10,000-hectare (almost 25,000 acres) RLX Projects are contiguous to various Evolution Mining, Great Bear Resources, Pacton Gold and Dixie Gold properties. Its 2,000-hectare (just under 5,000 acres) Belanger Project is contiguous to Infinite Ore’s Fredart and Garnet/Arrow properties. StraightUp intends to conduct exploration on the RLX North, RLX South, Belanger and Ferdinand Gold properties located in the Red Lake District, a location touted as having one of the best metal-endowed greenstone belts in the world. The Bear Head Gold Project is located within the Meen-Dempster Greenstone Belt of the Uchi Subprovince, approximately 80 kilometers west of the Pickle Lake Gold Camp and 14 km northeast of the former gold mine, Golden Patricia. It amassed 620,000 ounces of gold at an average of 15.2 g/t Au from 1988-1997. The property is bordered by an Australian miner massive gold project. Known gold occurrences are already mapped on the Bear Head property, as are previous drill holes and results. Once the data is re-examined, an exploration budget and subsequent plans will be announced by the company.

Projects

Ontario’s Red Lake Mining District is one of Canada’s most prolific gold mining districts, renowned for its high-grade gold deposits. This is a mining-friendly, politically stable jurisdiction with a skilled labor force and infrastructure specifically built around meeting the needs of the mining industry.

RLX North & South Projects
At over 10,000 hectares, the RLX North and RLX South Projects represent a district-scale exploration opportunity. The RLX North and RLX South Projects are well positioned on-strike to the southeast of the district’s largest gold deposit (Red Lake Gold Mines – Evolution Mining). The project is adjacent to Great Bear Resources’ Sobel Project. Great Bear Resources is also in the process of evaluating the area for significant regional-scale structural controls and has proposed additional work on its neighboring project in the near term. These properties are highly accessible, with the southern boundary only eight kilometers from the paved highway into Red Lake, and can be accessed by forest service roads which traverse throughout the properties.

Belanger Project
Historic exploration work on the 2,000-hectare property has identified three significant surface exposures of gold, copper and silver. Early exploration work will focus on validating historic sampling results and following the occurrences along strike with a view to better understanding the nature and controls on mineralization. The property has excellent forest road access from the town of Ear Falls.

Ferdinand Gold Project
The Ferdinand property is situated within the southeastern extension of the Confederation-Uchi greenstone belt, one of the most metal-endowed greenstone belts in the world by square kilometer. It consists of 17 contiguous mining claims covering approximately 7,143 hectares (17,650 acres), located 13 kilometers northwest of the town of Slate Falls. Access is currently by logging roads, with forestry logging operations scheduled for expansion on the property. StraightUp recently completed a heliborne magnetic survey consisting of 1,994 line-km at 50m line spacings covering the entire property. The MAG survey was designed to provide geological and structural details of a 25km long southeast extension of the Confederation-Uchi greenstone belt along the Fry-Bamaji Deformation Zone.

Bear Head Gold Project
The Bear Head Gold Project comprises 31 mining claims totaling 1,944 hectares (4,800 acres) in the Meen-Dempster Greenstone Belt of the Uchi Subprovince, host to the Golden Patricia former gold mine, which produced 620,000 ounces of gold from 1988 to 1997. The Dorothy Main gold deposit owned by Ardiden lies only one kilometer from the Bear Head Gold Project. The Dorothy Main gold deposit holds noncompliant historical resources of 46,600 ounces of gold at 6.17 g/t Au. The company looks forward to adding the Bear Head Gold Project to its exploration efforts, with a work program to be conducted later in the fall of 2021.

Management Team

Mark Brezer is CEO, President, and Director of StraightUp Resources Inc. He is a successful businessman and holds a Geography/Geology degree from the University of Arizona. He has worked as a Project Manager and has overseen quality control, environmental monitoring and safety programs related to road construction. He has also held roles in media relations and marketing. He has been actively involved in the research and investment of junior mining companies for over 25 years. Time in the field and personal interest led him into extensive first aid training, and he is certified as a paramedic and firefighter.

Daniel Cruz is CFO and Director at StraightUp Resources. He is an experienced financial industry professional, having worked for 12 years as a senior investment advisor at Canadian broker-dealers, where he gained experience in equity research, asset management, investor relations, corporate finance and venture capital. He was one of the youngest Senior Investment Advisors at Canaccord Financial Inc. in 2010. He is also the co-founder and current director of Liquid Media Group Inc., a Nasdaq-listed issuer. During his tenure as CFO, he helped that company list on Nasdaq and raise over $20 million.

Matthew Coltura is a Director at StraightUp Resources. He has a Bachelor of Business Administration from Okanagan College, where he specialized in finance. He has worked in the finance industry for more than three years. Currently, Mr. Coltura is the CFO of Cayenne Capital Corp. He was also a director of PreveCeutical Medical Inc. from July 2016 to September 2019, a director of Sproutly Canada Inc. (formerly Stoneridge Exploration Corp.) from March 2015 to July 2018, and, since March 2018, has worked as a financial specialist at Quip Finance.

StraightUp Resources Inc. (OTCQB: STUPF), closed Tuesday’s trading session at $0.11793, up 3.1759%, on 3,900 volume. The average volume for the last 3 months is 3,900 and the stock's 52-week low/high is $0.10676/$0.26.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

Friendable (OTC: FDBL) CEO Robert A. Rositano Jr. is spotlighted in a recent Authority Magazine article. The article, titled “5 Things I Wish Someone Had Told Me Before I Became a Founder,” shared insights from Rositano, who is also the founder of Friendable, a mobile technology and marketing company. Authority Magazine is a Medium publication devoted to sharing interesting “interview series” featuring people recognized as professionals and experts in business, film, sports and tech. In the article, Rositano shares insights that could help others avoid costly mistakes; he also discusses the company’s plans to expand its flagship Fan Pass service, the livestream artist platform that is revolutionizing the music industry. “We are on the move as the New Year approaches and intend to bring more awareness to our brand, community and platform with a variety of new service offerings set to enhance all artist and fan experiences,” said Friendable CEO and founder Robert Rositano Jr. in the press release. “To be interviewed by Authority Magazine puts Friendable, Fan Pass, myself and my brother/partner in a very elite class among those who have been previously interviewed by the Authority team, including the founders of GoPro, Zoom, Zappos, Adobe and Cisco. Thank you to our team, partners and our shareholders for their continued support. We are ready for an exciting 2022.” To view the full article, visit https://ibn.fm/a1Zil. To view the full press release, visit https://ibn.fm/kEA0j

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from Livestream.com. The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., Nettaxi.com and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Tuesday’s trading session at $0.0041, up 2.5%, on 2,093,320 volume. The average volume for the last 3 months is 2.093M and the stock's 52-week low/high is $0.0028/$0.0979.

Recent News

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

  • Education and job opportunities are being created for the sector, as more states and more countries around the word are pushing for cannabis legalization
  • MCOA offers diverse operations that include both wholly-owned subsidiaries and investment interests, including Cannabis Global Inc., Eco Innovation Group Inc., and Natural Plant Extract
  • During Q3 2021, the company saw its highest revenue earning quarter since it became public 

Despite challenges posed by the global pandemic, the legalized cannabis market is expected to grow significantly in the next five years. The market was valued at approximately $19.96 billion in 2018, and it is expected to grow at a CAGR of 17.2% during the forecast period, most likely topping $81.47 billion by the end of 2027, according to a recent market forecast report from Transparency Market Research (https://cnw.fm/KR9PM). Investing directly in the cannabis sector, Marijuana Company of America (OTC: MCOA) is uniquely positioned to benefit from the cannabis market’s growth and associated opportunities. The company offers diverse operations that include cDistro, one of the THC, hemp, and CBD industry’s fastest-growing distribution companies. MCOA operations also include hempsmart(TM) and VBF brands, a premium CBD company, and a cannabis nursery cultivation facility in Salinas, California, respectively.

Marijuana Company of America Inc. (OTC: MCOA) operates and invests in the cannabis sector directly. The company’s diverse operations include cDistro, one of the THC, hemp & CBD cannabis industries’ fastest growing distribution companies; hempsmart™, a premium CBD company; and VBF Brands Inc., a cannabis nursery cultivation facility in Salinas, California, that is a cultivator and distributor utilizing its own growing systems to produce desirable cannabis clones.

MCOA continues to grow its business while remaining fiscally conscious and further establishing itself in the legalized cannabis THC, hemp & CBD industries by offering unique exposure to the global cannabidiol sector. The company intends to continue to leverage its premium brand hemp-based products with investments in and collaboration with existing and new strategic partners.

Marijuana Company of America offers investors the opportunity to be at the forefront of innovation in the legal cannabis and industrial hemp industries.
During the summer of 2021, the U.S. witnessed the introduction of the most comprehensive cannabis reform ever proposed at the federal level, as well as ongoing state-level liberalization. The investments MCOA has made will position the company to drive the expected strongest revenue growth in the company’s history.

MCOA strives to develop a comprehensive selection of synergistic companies that provides consistent value to its shareholders. Furthermore, its vertically integrated business model provides companies and partners with the best opportunities for rapid growth. It is MCOA’s attention to detail in producing premium products and adhering to the best business practices that distinguish it among the leaders of cannabis products in the global marketplace.

MCOA is building a portfolio of investments and joint ventures that represent the highest integrity and professionalism in the legal cannabis and industrial hemp markets. MCOA is a model for entrepreneurs and businesses that share its common goals and philosophies of not only creating value for investors but also creating an environment for businesses to improve the quality of life of customers through sustainable alternatives to many products currently on the market.

Partnerships and Investments

MCOA has partnered with and invested in a portfolio of companies operating in the cannabis sector. These include:

Cannabis Global Inc.

Cannabis Global Inc. (OTC: CBGL) is an emerging force in the cannabis marketplace with growing product and intellectual property portfolios. CBGL is marketing and producing Comply Bag™, an innovative solution for cannabis storage, transport, and tracking, and is also the developer and marketer of the Hemp You Can Feel™ brand.

Eco Innovation Group Inc.

Eco Innovation Group Inc. (OTC: ECOX) works with inventors and other professionals to nurture and catalyze the most innovative and impactful products and services and deliver those innovations to market. ECOX is dedicated to developing and commercializing successful products.

MCOA’s investment supports Eco Innovation’s cutting-edge extraction technology. ECOX’s extraction processes utilize a proprietary formulation to extract valuable bioactive compounds from cannabidiol (CBD) combined with plant-based materials to create a fluid and cost-effective output.

Together, both companies are positioned to identify and accelerate the development of new varieties of hemp-based products and distribute them worldwide.

Natural Plant Extract

MCOA owns a direct investment interest in Natural Plant Extract (NPE), which operates a licensed cannabis manufacturing and distribution business in Lynwood, California. NPE holds a Type 7 California manufacturing and distribution license, allowing for cannabis product distribution anywhere in the State of California.

Wholly Owned Subsidiaries

hempsmart™

hempsmart™ is a CBD company focused on creating and promoting the most effective, best tasting, and highest quality products on the market.

In 2021, hempsmart expanded into the global marketplace and announced a rebrand that featured a fresh take on its packaging and a social media campaign to engage customers via Instagram, Twitter, TikTok, and more, which has now generated a new loyal group of followers.

hempsmart premier products include its Smart Drops (CBD Drops), Neuro Smart (Patented Brain Pills), and Smart Cream (Pain Cream) brands. These organic, plant-based products help to manage anxiety, pain and insomnia, without the inclusion of THC.

cDistro

cDistro distributes CBD brands, along with smoke and vape shop-related products, to wholesalers, c-stores, specialty retailers, and consumers in North America.
cDistro was chosen as one of the first to distribute Marley One, the first global functional mushroom brand, in collaboration with the Bob Marley Family.
The initial product offering will include a range of functional mushroom tinctures, including species such as cordyceps, lion’s mane, chaga, reishi and turkey tail, that offer a range of unique health and wellness benefits, from immunity and gut health to cognitive function and sleep enhancement.

VBF Brands Inc.

MCOA recently completed the acquisition of VBF Brands Inc., a fully licensed marijuana cultivator and distributor based in Salinas, California. VBF utilizes its own growing systems to produce desirable cannabis clones that are designed to assist growers by reducing uncertainty and enhancing the likelihood of a successful cultivation harvest. Cannabis clones carry the exact same genetic potential as their mother plants and have similar cannabinoid and terpene profiles when grown properly.

This subsidiary will immediately work toward increasing production at its Salinas facility, which also offers exponential growth potential with other nearby properties that MCOA has an option to participate in as part of the acquisition.

Market Outlook

Ongoing changes in U.S. state government policies toward cannabis are expected to cause demand for legal marijuana to surge. In addition, the number of indications for which medical marijuana is prescribed continues to increase. These factors are expected to rapidly boost legal sales of cannabis products. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will increase opportunities for this market.

According to a Grand View Research report, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a CAGR of 26.7 percent from 2021 to 2028. That would put the market value at roughly $30 billion by 2025.

The report cites the growing number of countries that are legalizing cannabis as a driver for surging demand. It also points out the use of medical marijuana for various ailments is gaining momentum worldwide. Medical marijuana is prescribed for patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s and other neurological disorders. The demand for cannabis oil is also increasing rapidly, especially among countries with legalized medical marijuana.

Management Team

Jesus Quintero is the CEO and Chairman of MCOA. From January 2013 to September 2014, he was the Chief Financial Officer of Brazil Interactive Media Inc. Since 2011, he has served as a financial consultant to several multimillion-dollar businesses in South Florida. He has extensive experience in public company reporting and SEC/SOX compliance and held senior finance positions with Avnet Inc., Latin Node Inc., Globetel Communications Corp., and Telefonica of Spain. His prior experience also includes positions at Price Waterhouse and Deloitte & Touche. He holds a B.S. in Accounting from St. John’s University and is a certified public accountant.

Marijuana Company of America Inc. (MCOA), closed Tuesday’s trading session at $0.0013, up 8.3333%, on 62,677,189 volume. The average volume for the last 3 months is 62.677M and the stock's 52-week low/high is $0.001/$0.0398.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has appointed an agriculture advisor; University of Guelph professor and researcher Dr. Claudia Wagner-Riddle will fill the role. In the announcement, the company noted that agriculture is the first sector FuelPositive plans to help transition away from the current seriously problematic and exploitative traditional ammonia supply chain. Wagner-Riddle is uniquely qualified to lead the company’s efforts in this focus. She leads a research program utilizing the measurement of greenhouse gas emissions to determine the carbon footprint of food, feed and fuel produced by agriculture as well as several projects dedicated to evaluating how soil health impacts ecosystem services. In addition, FuelPositive announced that company CEO, founder and director Ian Clifford was featured in a recent episode of The Tactical Leader podcast series. The series features industry innovators sharing their journeys of self-mastery and discussing their efforts to define the art of true leadership. “It’s our belief that the best way to deliver excellence is to invite excellent people to join our team,” said Clifford, regarding the appointment of Wagner-Riddle. “We are delighted to have Dr. Wagner-Riddle advising us, as we build our green ammonia production systems, to help farmers reduce their carbon footprints and take control of their fertilizer and fuel supply. Her knowledge of the impact of farming on the environment and the impact that climate change has on farming is already ensuring we are making the right decisions to provide the maximum benefit to farmers.” To view Clifford’s full interview, visit https://ibn.fm/8N0VB. To view the full press releases, visit https://ibn.fm/qTFqz and https://ibn.fm/924JK

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Tuesday’s trading session at $0.147, even for the day, on 281,167 volume. The average volume for the last 3 months is 281,167 and the stock's 52-week low/high is $0.03224/$0.326.

Recent News

RYAH Group Inc. (CSE: RYAH)

The QualityStocks Daily Newsletter would like to spotlight RYAH Group Inc. (CSE: RYAH).

You have probably heard about CBD, either from the media or in person, especially in regard to its medical potential. Cannabidiol (“CBD”) came into the limelight when the 2018 farm bill federally legalized the cultivation and sale of industrial hemp and its derivatives, including CBD. Although hemp is in the cannabis family, CBD extracted from legal industrial hemp will not intoxicate you. However, CBD still shares plenty of medical properties with THC, the main psychoactive agent in marijuana, and several studies have found that cannabidiol can aid in post-cancer recovery. Such cannabis-based treatments may stand a higher chance of being beneficial when taken using an IoT-enabled dose-measuring device such as those produced by RYAH Group Inc. (CSE: RYAH) and other such companies.

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Product Portfolio

The company’s current portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component and the mobile application. The product line currently includes a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage.

RYAH Smart-Inhaler

The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and presets for temperatures and dosages, all of which can be customized to individual needs and doctor recommendations, as well as a post-session review mechanism that allows the collection of session data and feedback for further efficacy analysis for customized dosing capabilities.

RYAH’s proprietary stainless-steel cartridges for the inhaler use QR technology that contains lab testing and grower information pertaining to the specific strain, thereby mitigating elicit product use and enabling completely transparent remote medicinal analytics, from seed to consumption.

In addition, the RYAH Cartridges provide a unique closed-loop recurring revenue opportunity for the company, as the RYAH Inhaler only works with this type of proprietary cartridges that licensed partners fill with medicine. The partners benefit from all the back-end data, providing them access to consumption habits, statistics and other data on patient preferences.

RYAH Smart-Patch

The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and the heating element is completely IoT and controlled by RYAH’s proprietary smartphone applications, which allows scheduling and ‘boosting’ medicine release, on-demand.

RYAH Smart-Pen

The RYAH Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect’, enabling customized, wide-spectrum recommendation opportunities by licensed clinicians. The Smart-Pen will feature cartridges that contain CBD, THC and other isolates such as flavonoids or vitamins, or other solutions. There is a built-in mechanism designed to control usage based on recommended dosing schedules.

RYAH MD

RYAH MD serves as a remote and interactive patient-doctor collaboration and dosing administration platform. Doctors can remotely set dosage amounts for their patients, creating digital prescriptions for the RYAH IoT devices and tracking patient usage in real-time. RYAH MD offers features that include real-time monitoring, appointment booking, doctor-patient video calls and science-based strain recommendations, as well as promoting a better understanding of the effects and benefits of those recommendations among patients. Information is gathered from all of the RYAH devices.

PotBot App

The PotBot App is a medical cannabis education mobile application that leverages patented AI technology to capture structured and unstructured data to assist patients in learning about various treatments in plant-medicine based on their efficacy goals. The PotBot App is currently one of the top-rated medical cannabis educational mobile applications on the Apple App Store in the United States, with over 300,000 downloads.

Through the combination of peer-reviewed and empirical data, the PotBot App provides detailed information on the targeted and tested cannabinoid levels and associated strains from cannabis patients. The result is personalized and driven by data to inform patients of potential product matches associated with similar ailments and efficacy goals.

Market Outlook

RYAH holds a unique position in the $100.3 billion medical plant market, with the potential to capture and capitalize on growth opportunities made available by both the IoT and Data Intelligence sectors.

In 2018, the global IoT market was valued at $212.1 billion, and it is expected to grow exponentially to $1.3 trillion by 2026, registering a CAGR of 25.68%, according to Verified Market Research (https://ibn.fm/XtkPZ).

Management Team

Dr. Boris Goldstein, Ph.D., is the founder and Chairman of RYAH Group. He is a seasoned entrepreneur, investment banker and venture capitalist. He started his career as the founder of Software House HT, which grew into a worldwide corporation with over 40 offices in 17 countries. Since then, Goldstein has founded and served on the boards of directors and advisory boards for numerous companies in Silicon Valley and Silicon Alley. Goldstein brings experience in fundamental research, investment and technology, authoring multiple patents and books.

Gregory Wagner, MBA, is Chief Executive Officer and Director of RYAH Group. He has over 20 years of experience in global financial markets and entrepreneurship. Wagner has held executive roles in the United States and London. He has co-founded and built several startups from the ground up. His current licensures and degrees include FINRA Series 7, 63, 24 and 55, as well as an MBA from Fordham University. Wagner received a Certification in Innovation and Strategy from Harvard University.

RYAH Group Inc. (CSE: RYAH), closed Tuesday’s trading session at $0.035, even for the day. The average volume for the last 3 months is 601,830 and the stock's 52-week low/high is $0.03/$0.20.

Recent News

Save Foods Inc. (NASDAQ: SVFD)

The QualityStocks Daily Newsletter would like to spotlight Save Foods Inc. (NASDAQ: SVFD).

Save Foods (NASDAQ: SVFD), an Israeli-based developer of eco-friendly solutions specifically designed to ensure food safety and extend shelf life of fruit and vegetables, has begun a commercial program to introduce new products in Mexico. The company is working with Agrinet S.A., an agritech consultancy firm. Save Foods identified Mexico as an ideal expansion location because the country is a world leader in the production and exportation of fruits and vegetables. To begin with, SVFD’s program will include three packing house companies in Mexico that export to the United States and other global destinations. Save Foods will focus on offering products designed to prevent citrus, avocado, bell peppers and tomato waste and loss. “As food concern continues to grow globally, demand for Save Foods’ effective food safety solutions is at a real tipping point,” said Save Foods CEO Dan Sztybel in the press release. “The success of our ongoing commercial programs around the world, especially in Mexico where we already sell to Sicar Farms, which recently converted four packing facilities responsible for the production of 40,000 ha of limes to use Save Foods’ products, led us to the decision to quickly expand our presence in Mexico. Mexican agriculture is thriving, and the growing export market is helping drive the economy. Packing houses are eager to implement our products because they are highly cost-effective. The plug and play nature of integration means no upfront or extra expenses, while ensuring food safety, increasing shelf life and reducing waste, which ultimately positively affects their bottom line.” To view the full press release, visit https://ibn.fm/87JTU

Save Foods Inc. (NASDAQ: SVFD) is an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables. The company is focused on addressing two of the most significant challenges faced by the industry: (1) food waste and loss, and (2) food safety.

Fungi like mold and yeast, as well as foodborne pathogens, are typically responsible for fresh produce spoilage and foodborne illness. Save Foods’ integrated solutions improve safety, freshness and quality every step of the way, from field to fork. The company’s natural products control human and plant pathogens, allowing growers, packers and food retailers to reduce waste and boost revenues. More food ends up on consumers’ plates, and less ends up in landfills.

Save Foods’ products use all-natural ingredients to protect fresh produce from microbial spoilage and pathogens with zero toxicity. The company’s treatments leave no harmful residues on produce or in the environment and maintain product freshness over time. Fresh produce treated with Save Foods’ products can already be found in supermarket chains across the U.S. and Europe. Those chains have reported that the company’s products are reducing fruit spoilage by 50% on average at the retail level. With no need for additional steps in the treatment process nor special equipment, Save Foods’ products are easy to implement and come in versatile applications suitable for the different stakeholders along the food supply chain.

Initial applications for the company’s offerings include post-harvest treatments in fruit and vegetable packing houses that process citrus, avocados, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of chemicals and their residues, Save Foods’ products not only prolong shelf life; they also ensure safe, natural and healthy food. Save Foods has the first green products that could realistically replace the different chemicals used today in food treatment while controlling waste and food safety.

Products & Technology

  • SavePROTECT or PeroStar, a processing aid added to fruit and vegetable wash water and used in post-harvest treatment;
  • SF3HS and SF3H, post-harvest treartment solutions to control both plant and foodborne pathogens;
  • SpuDefender, for controlling post-harvest potato sprouts; and
  • FreshPROTECT, for controlling spoilage microorganisms on post-harvest citrus.

Save Foods’ products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of sanitizers and fungicides at low concentrations in a non-organic setting. The combination eliminates fungicide residues or reduces them to levels below the established Maximum Residue Levels (MRLs). The company’s fruit and vegetable wash is odorless and does not irritate human eyes, skin or airways. Save Foods’ blend does not leave any residues of toxicological concern on the treated surface of produce, and all its ingredients are classified by the U.S. Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS). There are 7 patent families related to Save Foods’ technology.

Applications

The company’s products have been commercially validated on citrus, mangos, avocados, pears, bell peppers, microgreens and various fresh cut vegetables. Save Foods is in the validation process for bananas, apples, figs, berries, lettuce, papayas and more. The company is also validating the efficacy of its products for pre-harvest treatment, starting with citrus trees.

Market Outlook

The world population is expected to grow to almost 10 billion by 2050, boosting current agricultural demand by some 50%. Providing healthy and safe food for the world’s population is one of the biggest challenges of the 21st century.

Globally, around 664 million tons of fresh fruits and vegetables are lost every year from field to fork, wasted by spoilage, and almost one in 10 people globally falls ill every year from eating contaminated food, with an estimated resulting cost around $90 billion.

Disposing of all that wasted food requires additional expense and harms the environment with resulting greenhouse gas emissions. The post-harvest food treatment market was valued at $1.5 billion in 2019 and is expected to grow to $2.3 billion by 2026, achieving a CAGR of 6.5%.

Management Team

David Palach is CEO of Save Foods. He spent over a decade with Intel Israel, where his last position was Manager of Business Development for Israel and Europe. Prior to that, he served as a controller of two of Intel’s largest factories in Israel, where he supervised a budget of over $1 billion. He also served as the CEO of B-Pure Corporation Ltd., a management and maintenance company involved in protecting and improving the environment. During his tenure, he helped turn around several struggling subsidiaries and made them profitable.

Vered Raz Avayo is the company’s CFO. Before joining SaveFoods in 2018, she spent more than 10 years as CFO at LGC, the Leviev Group of Companies. She has operated her own financial and business consultancy and has served as a director for a number of public companies in Israel.

Dan Sztybel is CEO of SaveFoods Ltd., the Israeli subsidiary of Save Foods Inc. He previously led the Life Sciences Advisory at EY Israel and early on recognized the potential of Israel as a center of innovation in the digital health space. He has been an adviser on digital health strategy to large pharmaceutical companies and is a cofounder of MyndYou, a digital health start-up focusing on cognitive impairment. He is also a co-founder of the DigitalHealth.il conference, the largest digital health conference in Israel.

Dr. Neta Matis is Vice President of R&D at Save Foods Ltd the Israeli subsidiary of Save Foods Inc . She holds a Ph.D. in organic chemistry and an MBA from Tel Aviv University. Prior to joining Save Foods in 2019, she held multiple research chemist and product development roles at Verdia Inc. and its parent company, Helsinki-based Stora Enso Oyj.

Nimrod Ben Yehuda is the founder and CTO of Save Foods Ltd. He was previously the CEO/CTO of Swissteril Water Purifications Ltd. He has also been CEO at Nir Ecology Ltd., and was Joint-CEO at NitroJet Ltd.

Dr. Art Dawson is the U.S. Business Manager for SaveFoods Inc. He has been president of The Dawson Company, which focuses on creating sales opportunities for new agricultural technologies, previously Dr. Dawson held senior industry positions like General Manager Worldwide of the Decco , the Post Harvest Division for Elf Atochem. He holds a Ph.D. in Plant Physiology from UC Riverside and is licensed in California as an agricultural Pest Control Advisor.

Save Foods Inc. (SVFD), closed Tuesday’s trading session at $4.3, off by 4.8673%, on 27,501 volume. The average volume for the last 3 months is 27,489 and the stock's 52-week low/high is $3.67/$30.10.

Recent News

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC)

The QualityStocks Daily Newsletter would like to spotlight BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

  • BevCanna Enterprises’ TRACE line of natural alkaline and mineral-infused spring waters have been named as the official water supplier for Vancouver’s 2022 Canadian E-Prix event
  • TRACE Natural Alkaline Spring Water, which originates from BevCanna’s wholly owned natural spring water aquifer in British Columbia, are renowned for their optimal mineral content and eco-friendly packaging
  • BevCanna will launch a unique, commemorative package for its signature water brand in the run-up to the Vancouver E-Prix
  • The event will serve to further propagate the TRACE brand name, with the company already named as the official water supplier to British Columbia’s firefighters

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, which includes the highly anticipated Formula E electric car race (https://cnw.fm/wOlJj).

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale.

BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands.

Based in British Columbia, Canada, BevCanna was founded in 2017.

End-to-End Turnkey Beverage Manufacturing Solutions

BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

  • Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
  • Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
  • Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
  • Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
  • Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands

BevCanna’s in-house brands include Pure Therapy and TRACE.

Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (CBD) products, throughout North America and Western Europe.

Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise.

TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels.

Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness.

TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots.

In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages.

Market Outlook for Cannabis-Infused Beverages

In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (https://ibn.fm/VkJfH).

The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces.

Management Team

Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand.

John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd.

Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years.

Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise.

Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL).

Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years.

Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries.

Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY).

BevCanna Enterprises Inc. (OTCQB: BVNNF), closed Tuesday’s trading session at $0.1624, off by 1.5758%, on 47,235 volume. The average volume for the last 3 months is 47,235 and the stock's 52-week low/high is $0.14/$1.20.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

  • As plant-based foods establish a growing market sector, wholesome lifestyle brand builder PlantX Life is expanding its plant-based brick and mortar presence from its flagship Canadian store to outlets in the United States and Israel as well
  • PlantX Life is building an e-commerce and plant-based community sustaining presence online through a platform that partners with its growing storefront profile
  • The company’s efforts have resulted in record revenues this holiday season, with 63 percent growth during Black Friday and Cyber Monday promotions over last year’s sales during the holiday
  • PlantX markets over 5,000 products currently and aims to become a one-stop source for the plant-based community’s needs, not only providing products for sale but information that helps newly arriving consumers adopt a wellness lifestyle and established plant-based community members increase their opportunities

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), is making a name for itself by combining its mission of plant-based lifestyle education with profit-generating product placement, both through online branding and an attractive storefront profile, and now reports record holiday season sales. PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) CEO and president Lorne Rapkin was profiled on the EDGE Podcast, hosted by Brandon C. White. During the interview, Rapkin discussed his background, noting that he was an entrepreneur at an early age, building and running companies even when he was in school. He also talked about PlantX and its efforts to become a trusted and convenient destination for people living plant-based lives. EDGE Podcast features a series of interviews focused on providing the business owner's playbook about the inner game of building a successful business and giving listeners the edge to become smarter, healthier and richer. “Obviously being in the plant-based space in this day and age is very attractive,” said Rapkin in the interview. “Our business is food, and people always need to consume food. They’re always looking for different options and varieties. . . . It just so happened that when we started this company. . . it was at the inception of the plant-based space becoming very exciting and very popular, but also the pandemic, when people were stuck in their homes and looking for ways to get access to healthier food. We were one of the early providers of those offerings. That’s really where PlantX started. It was a vision to provide an alternative when plant-based food and delivery wasn’t really on the map. . . . I was one of the starting four of the company. Today, we’ve got over 75 people in the business. Over 18 months, we’ve grown this thing from operating one website and doing B2C to now operating in multiple countries and continuing to scale into a global operation.” To view the full interview, visit https://ibn.fm/LjDlh. To view the full press release, visit https://ibn.fm/9z1yF

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Tuesday’s trading session at $0.16355, off by 6.1406%, on 226,422 volume. The average volume for the last 3 months is 226,422 and the stock's 52-week low/high is $0.146/$1.85.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading